- Release Date: 24/06/22 10:04
- Summary: First phase 1B trial of NK cells with IL-2 & Vactosertib
- Price Sensitive: No
- Download Document 260.36KB
Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $2.661K | 665.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1896786 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 15547457 | 25 |
View Market Depth
| Last trade - 10.07am 23/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |